People suffering from chronic liver and kidney diseases, as well as those with learning disabilities, are at greater risk of dying from sepsis, scientists have warned. Patients with some of these conditions are three times more likely to die from an infection within a month, and those with kidney disease are up to six times more at risk, a new study of NHS data has found.
Being from a poor background can also lead to an 80% greater risk of developing sepsis and dying, the experts said. The new research found those who have a “history of extensive antibiotic exposure” are also at higher risk. Professor Tjeerd van Staa, from the University of Manchester who co-authored the study, said:
“This study shows socioeconomic deprivation, comorbidity and learning disabilities are associated with an increased risk of developing non-COVID-19-related sepsis and 30-day mortality in England….Story continues…..
Source: Study reveals which people are most likely to die from sepsis | The Independent
.
Critics:
Sepsis is a potentially life-threatening condition that arises when the body’s response to infection causes injury to its own tissues and organs.This rate, increased breathing rate, and confusion. There may also be symptoms related to a specific infection, such as a cough with pneumonia, or painful urination with a kidney infection.
The very young, old, and people with a weakened immune system may have no symptoms of a specific infection, and the body temperature may be low or normal instead of having a fever. Severe sepsis causes poor organ function or blood flow. The presence of low blood pressure, high blood lactate, or low urine output may suggest poor blood flow.
Septic shock is low blood pressure due to sepsis that does not improve after fluid replacement. Sepsis is caused by many organisms including bacteria, viruses and fungi. Common locations for the primary infection include the lungs, brain, urinary tract, skin, and abdominal organs.
Risk factors include being very young or old, a weakened immune system from conditions such as cancer or diabetes, major trauma, and burns. Previously, a sepsis diagnosis required the presence of at least two systemic inflammatory response syndrome (SIRS) criteria in the setting of presumed infection. In 2016, a shortened sequential organ failure assessment score (SOFA score), known as the quick SOFA score (qSOFA), replaced the SIRS system of diagnosis.
qSOFA criteria for sepsis include at least two of the following three: increased breathing rate, change in the level of consciousness, and low blood pressure. Sepsis guidelines recommend obtaining blood cultures before starting antibiotics; however, the diagnosis does not require the blood to be infected. Medical imaging is helpful when looking for the possible location of the infection.
Other potential causes of similar signs and symptoms include anaphylaxis, adrenal insufficiency, low blood volume, heart failure, and pulmonary embolism. Sepsis requires immediate treatment with intravenous fluids and antimicrobials. Ongoing care often continues in an intensive care unit. If an adequate trial of fluid replacement is not enough to maintain blood pressure, then the use of medications that raise blood pressure becomes necessary.
Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. A central venous catheter and an arterial catheter may be placed for access to the bloodstream and to guide treatment. Other helpful measurements include cardiac output and superior vena cava oxygen saturation.
People with sepsis need preventive measures for deep vein thrombosis, stress ulcers, and pressure ulcers unless other conditions prevent such interventions. Some people might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not. Disease severity partly determines the outcome.
The risk of death from sepsis is as high as 30%, while for severe sepsis it is as high as 50%, and septic shock 80%. Sepsis affected about 49 million people in 2017, with 11 million deaths (1 in 5 deaths worldwide). In the developed world, approximately 0.2 to 3 people per 1000 are affected by sepsis yearly, resulting in about a million cases per year in the United States. Rates of disease have been increasing.
Some data indicate that sepsis is more common among males than females, however, other data show a greater prevalence of the disease among women. Descriptions of sepsis date back to the time of Hippocrates. In addition to symptoms related to the actual cause, people with sepsis may have a fever, low body temperature, rapid breathing, a fast heart rate, confusion, and edema. Early signs include a rapid heart rate, decreased urination, and high blood sugar.
Signs of established sepsis include confusion, metabolic acidosis (which may be accompanied by a faster breathing rate that leads to respiratory alkalosis), low blood pressure due to decreased systemic vascular resistance, higher cardiac output, and disorders in blood-clotting that may lead to organ failure.Fever is the most common presenting symptom in sepsis, but fever may be absent in some people such as the elderly or those who are immunocompromised.
The drop in blood pressure seen in sepsis can cause lightheadedness and is part of the criteria for septic shock. Oxidative stress is observed in septic shock, with circulating levels of copper and vitamin C being decreased. Diastolic blood pressure falls during the early stages of sepsis, causing a widening/increasing of pulse pressure, which is the difference between the systolic and diastolic blood pressures.
If sepsis becomes severe and hemodynamic compromise advances, the systolic pressure also decreases, causing a narrowing/decreasing of pulse pressure. A pulse pressure of over 70 mmHg in patients with sepsis is correlated with an increased chance of survival. A widened pulse pressure is also correlated with an increased chance that someone with sepsis will benefit from and respond to IV fluids.
“Sepsis Questions and Answers”. (American College of Emergency Physicians) (2011). “Ch. 146: Septic Shock”. In Tintinalli JE, Stapczynski JS, Ma OJ, Cline DM, Cydulka RK, Meckler GD (eds.). Tintinalli’s Emergency Medicine:
Sepsis: current dogma and new perspectives”.
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)”. JAMA. 315 (8): 801–810.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016″.
Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality”. Journal of Global Health. 2 (1): 010404. doi:10.7189/jogh.01.010404. PMC 3484761.
Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes”. Expert Review of Anti-Infective Therapy.
Severe sepsis and septic shock”. The New England Journal of Medicine.
Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis”. Cell Death & Disease. 10 (10):
Trends in Epidemiology and Microbiology of Severe Sepsis and Septic Shock in Children”. Hospital Pediatrics. 10 (12): 1021–1030.
Corticosteroids for treating sepsis in children and adults”.
Leave a Reply